Recruiting Bipolar Disorder Studies in Montclair
Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania
This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed fe...
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
The purpose of this study is to evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolar-I Disorder...
About Bipolar Disorder Clinical Trials in Montclair
Bipolar disorder is a mental health condition marked by extreme mood swings including emotional highs (mania or hypomania) and lows (depression). It affects about 2.8% of adults in the U.S. Treatment typically involves mood stabilizers, antipsychotics, and psychotherapy.
There are currently 2 bipolar disorder clinical trials recruiting participants in Montclair, CALIFORNIA. These studies are seeking a combined 624 participants. Research is being sponsored by Intra-Cellular Therapies, Inc., Bristol-Myers Squibb. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bipolar Disorder Clinical Trials in Montclair — FAQ
Are there bipolar disorder clinical trials in Montclair?
Yes, there are 2 bipolar disorder clinical trials currently recruiting in Montclair, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Montclair?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Montclair research site will contact you about next steps.
Are clinical trials in Montclair free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Montclair studies also compensate for your time and travel.
What bipolar disorder treatments are being tested?
The 2 active trials in Montclair are testing new therapies including novel drugs, biologics, and treatment approaches for bipolar disorder.
Data updated March 2, 2026 from ClinicalTrials.gov